Literature DB >> 25261648

Knockdown of CETN1 inhibits breast cancer cells proliferation.

Xu Shuangta1, He Yali, Zheng Zhengrong, Zhao Qingquan, Zeng Xiaoshan, Yao Fanghui, Waihung Ng, Liang Yinghui, Xu Jianhua.   

Abstract

PURPOSE: Breast cancer is a multifactorial disease and identification of the genes and proteins regulating breast carcinogenesis is critical in exploring novel targeted therapies. The aim of this study was to investigate the role CETN1 in breast cancer growth and metastasis.
METHODS: CETN1 expression levels were measured in breast tissue samples by immunohistochemistry (IHC). We selected high CETN1-expressing cell lines from human breast carcinoma cells with metastatic potential. The proliferation of cells was evaluated by MTS assay. Changes in progression of cell division were assessed by cell cycle analysis. Changes in CETN1 levels in breast tumor cells were analysed by Western blot.
RESULTS: Our results demonstrated that overexpression of CETN1 occurred mainly in breast cancer cells in which CETN1 expression was low. Knockdown of CETN1 by lentivirus- shRNA significantly inhibited breast cancer cells' proliferation, growth and metastasis.
CONCLUSION: CETN1 is overexpressed in breast cancer tissue and promotes cells'proliferation, tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261648

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  2 in total

1.  Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer.

Authors:  Wenting Wu; Erin K Wagner; Yangyang Hao; Xi Rao; Hongji Dai; Jiali Han; Jinhui Chen; Anna Maria V Storniolo; Yunlong Liu; Chunyan He
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

2.  Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer.

Authors:  Rubin Jiao; Kevin J H Allen; Mackenzie E Malo; Muath Helal; Zewei Jiang; Karishma Smart; Susan V Buhl; David Rickles; Ruth A Bryan; Ekaterina Dadachova
Journal:  Cancer Med       Date:  2019-07-16       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.